DK0885220T3 - Tropanderivater, deres fresmtilling og anvendelse - Google Patents

Tropanderivater, deres fresmtilling og anvendelse

Info

Publication number
DK0885220T3
DK0885220T3 DK97903355T DK97903355T DK0885220T3 DK 0885220 T3 DK0885220 T3 DK 0885220T3 DK 97903355 T DK97903355 T DK 97903355T DK 97903355 T DK97903355 T DK 97903355T DK 0885220 T3 DK0885220 T3 DK 0885220T3
Authority
DK
Denmark
Prior art keywords
disorders
derivatives
fresmation
application
monoamine neurotransmitter
Prior art date
Application number
DK97903355T
Other languages
English (en)
Inventor
Joergen Scheel-Krueger
Peter Moldt
Frank Waetjen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of DK0885220T3 publication Critical patent/DK0885220T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK97903355T 1996-02-22 1997-02-21 Tropanderivater, deres fresmtilling og anvendelse DK0885220T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK19496 1996-02-22
PCT/EP1997/000850 WO1997030997A1 (en) 1996-02-22 1997-02-21 Tropane-derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
DK0885220T3 true DK0885220T3 (da) 2001-10-15

Family

ID=8090830

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97903355T DK0885220T3 (da) 1996-02-22 1997-02-21 Tropanderivater, deres fresmtilling og anvendelse

Country Status (31)

Country Link
US (3) US6288079B1 (da)
EP (2) EP1130020A1 (da)
JP (1) JP3238414B2 (da)
KR (1) KR100446571B1 (da)
CN (1) CN1077574C (da)
AT (1) ATE203023T1 (da)
AU (1) AU720358B2 (da)
BG (1) BG63945B1 (da)
BR (1) BR9707636A (da)
CA (1) CA2244773C (da)
CZ (1) CZ287007B6 (da)
DE (1) DE69705608T2 (da)
DK (1) DK0885220T3 (da)
EE (1) EE04751B1 (da)
ES (1) ES2159839T3 (da)
GR (1) GR3036829T3 (da)
HU (1) HU228356B1 (da)
IL (1) IL125146A (da)
IS (1) IS1824B (da)
NO (1) NO318731B1 (da)
NZ (1) NZ330886A (da)
PL (1) PL185132B1 (da)
PT (1) PT885220E (da)
RU (1) RU2167876C2 (da)
SG (1) SG99853A1 (da)
SI (1) SI0885220T1 (da)
SK (1) SK281813B6 (da)
TR (1) TR199801641T2 (da)
UA (1) UA49872C2 (da)
WO (1) WO1997030997A1 (da)
ZA (1) ZA971525B (da)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018946A1 (en) * 1998-09-30 2000-04-06 Nihon Medi-Physics Co., Ltd. Process for producing optically active tropinone monocarboxylic acid derivative
AUPP627498A0 (en) 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
JP2005508872A (ja) * 2001-05-23 2005-04-07 ニューロサーチ、アクティーゼルスカブ トロパン誘導体及びこれをモノアミン神経伝達物質再取り込み阻害剤として使用する方法
DE20203103U1 (de) * 2001-10-11 2002-07-11 Organix, Inc., Woburn, Mass. Serotonin-Wiederaufnahme-Inhibitoren
WO2003037313A2 (en) * 2001-10-31 2003-05-08 Recovery Pharmaceuticals, Inc. Methods for the treatment of addiction
US7381733B2 (en) 2001-11-30 2008-06-03 Neurosearch A/S Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
EP1513529B1 (en) * 2002-05-30 2011-12-14 NeuroSearch A/S Triple monoamine reuptake inhibitors for the treatment of chronic pain
CA2502704A1 (en) 2002-11-01 2004-05-13 Neurosearch A/S Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US7507717B2 (en) 2002-12-02 2009-03-24 Xenome Ltd. Type II chi-conotoxin peptides (noradrenaline transporter inhibitors)
WO2004050690A1 (en) 2002-12-02 2004-06-17 Xenome Ltd NOVEL χ-CONOTOXIN PEPTIDES (-I)
CA2515584A1 (en) 2003-02-12 2004-08-26 Neurosearch A/S 8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
JP2006517567A (ja) 2003-02-12 2006-07-27 ニューロサーチ、アクティーゼルスカブ 新規８−アザ−ビシクロ［３．２．１］オクタン誘導体及びこれをモノアミン神経伝達物質再取り込み阻害薬として使用する方法
CN100551924C (zh) * 2003-02-12 2009-10-21 神经研究公司 8-氮杂-双环[3.2.1]辛烷衍生物和它们作为单胺神经递质再摄取抑制剂的用途
CN100372850C (zh) * 2003-02-12 2008-03-05 神经研究公司 新的8-氮杂-双环[3.2.1]辛烷衍生物和它们作为单胺神经递质再摄取抑制剂的用途
UA82517C2 (uk) 2003-06-24 2008-04-25 Ньюросерч А/С Нові похідні 8-аза-біцикло[3.2.1]октану та їх застосування як інгібіторів ресорбції моноамінових медіаторів
AR045141A1 (es) * 2003-07-31 2005-10-19 Neurosearch As Sales de tartrato de 2- metoximetil-3-(3,4-diclorofenil)-8-azabiciclo (3,2,1) octano. composiciones farmaceuticas que los contienen y usos de las mismas.
MXPA06003749A (es) 2003-10-03 2006-06-14 Pfizer Derivados de tropano.
EP2269608A3 (en) 2003-10-16 2011-02-16 NeuroSearch AS Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
MXPA06005545A (es) * 2003-11-18 2006-08-17 Boehringer Ingelheim Int Preparacion farmaceutica solida.
WO2005070429A1 (en) * 2004-01-22 2005-08-04 Neurosearch A/S Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
WO2005070428A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
AU2005205880B2 (en) * 2004-01-22 2010-06-10 Neurosearch A/S Compounds for the sustained reduction of body weight
DE102004004965B4 (de) * 2004-01-31 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung eines 2-(Ethoxymethyl)-tropanderivates
JP2008501656A (ja) * 2004-06-04 2008-01-24 ノイロサーチ アクティーゼルスカブ β−アミロイド（Ａβ４０及びＡβ４２）生成阻害のためのモノアミン神経伝達物質再取り込み阻害剤
US7524958B2 (en) 2004-06-18 2009-04-28 Neurosearch A/S Certain 9-aza-bicyclo[3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
CA2570075A1 (en) 2004-06-18 2005-12-29 Neurosearch A/S Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
EP1761527A1 (en) * 2004-06-18 2007-03-14 Neurosearch A/S Novel 9-aza-bicyclo¬3.3.1|nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
KR20070061846A (ko) 2004-09-30 2007-06-14 뉴로서치 에이/에스 신규한 크로멘-2-온 유도체 및 모노아민 신경전달물질재흡수 억제제로서의 이의 용도
EP1797088B1 (en) 2004-09-30 2011-01-05 NeuroSearch A/S Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2006084870A2 (en) 2005-02-10 2006-08-17 Neurosearch A/S Alkyl substituted homopiperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
EP1869050A1 (en) * 2005-04-04 2007-12-26 Neurosearch A/S Novel substituted diazabicyclo derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20090137625A1 (en) 2005-04-08 2009-05-28 Dan Peters Novel Enantiomers and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
ATE481386T1 (de) * 2005-06-28 2010-10-15 Neurosearch As Neue 3-aza-spiroä5.5üundec-8-en derivate und deren verwendung als inhibitoren der wiederaufnahme von monoaminneurotransmittern
WO2007000465A1 (en) * 2005-06-28 2007-01-04 Neurosearch A/S Novel 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US7943630B2 (en) * 2005-06-28 2011-05-17 Neurosearch A/S 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
EP1899301B1 (en) * 2005-06-28 2010-09-15 NeuroSearch A/S Novel 3-aza-spiro[5.5]undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2007006738A2 (en) * 2005-07-12 2007-01-18 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising 2 , 3-disubstituted tropanes for the treatment of disorders of sexual desire
KR101594898B1 (ko) 2005-07-15 2016-02-18 알바니 몰레큘라 리써치, 인크. 아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도
EP1919476A2 (en) * 2005-08-24 2008-05-14 Government of the United States of America, Represented by the Secretary, Department of Health and Human Services Benztropine compounds and uses thereof as dopamine uptake inhibitors
WO2007028770A1 (en) * 2005-09-05 2007-03-15 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitors for neuroprotection in patients suffering from an advanced stage of a mental disease
WO2007028769A1 (en) * 2005-09-05 2007-03-15 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitor for neuroprotection
EP1779851A1 (en) 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Treatment of diabetes
TW200804367A (en) 2005-11-11 2008-01-16 Neurosearch As Novel compounds
AU2007213669A1 (en) 2006-02-10 2007-08-16 Neurosearch A/S 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
TW200800980A (en) 2006-02-17 2008-01-01 Neurosearch As Novel compounds
US20100234349A1 (en) 2006-09-04 2010-09-16 Olsen Gunnar M Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
BRPI0716532A2 (pt) * 2006-09-11 2013-09-24 Glaxo Group Ltd compostos azabicÍclios como inidores de reabsorÇço de monoaminas
GB0703998D0 (en) * 2007-03-01 2007-04-11 Glaxo Group Ltd Novel salt
TW200904815A (en) 2007-05-09 2009-02-01 Neurosearch As Novel compounds
US20100286195A1 (en) * 2007-09-10 2010-11-11 Neurosearch A/S Novel benzooxazol-and benzooxathiol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
JP2010539075A (ja) * 2007-09-10 2010-12-16 ノイロサーチ アクティーゼルスカブ フェノキサジン−３−オンの新規誘導体、並びにモノアミン神経伝達物質再取り込み阻害剤としてのその使用
WO2009065845A1 (en) * 2007-11-20 2009-05-28 Neurosearch A/S A method for treating over-eating disorders
EP2222303A1 (en) * 2007-11-20 2010-09-01 NeuroSearch A/S A method for treating addiction
WO2010132487A1 (en) 2009-05-12 2010-11-18 Bristol-Myers Squibb Company CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
US8802696B2 (en) 2009-05-12 2014-08-12 Albany Molecular Research, Inc. 7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoqu inoli and use thereof
JP2012526744A (ja) 2009-05-15 2012-11-01 ノイロサーチ アクティーゼルスカブ クロメン−２−オン誘導体及びモノアミン神経伝達物質再取り込み阻害剤としてのそれらの使用
US20120220604A1 (en) 2009-09-21 2012-08-30 Neurosearch A/S Piperazinyl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2011092061A1 (en) 2010-01-29 2011-08-04 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2011117289A1 (en) 2010-03-25 2011-09-29 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neuro-transmitter re-uptake inhibitors
US8153653B2 (en) * 2010-06-22 2012-04-10 Hoffmann-La Roche Inc. Amido-tropane derivatives
WO2012000881A1 (en) 2010-07-02 2012-01-05 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2012024397A2 (en) 2010-08-17 2012-02-23 Albany Molecular Research, Inc. 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
CA2813911A1 (en) 2010-10-07 2012-04-12 Takeda Pharmaceutical Company Limited 1,4-oxazepane derivatives
JP6203760B2 (ja) 2012-02-16 2017-09-27 サニオナ・エー／エス 併用療法のための医薬組成物
US9579288B2 (en) 2015-03-03 2017-02-28 Saniona A/S Tesofensine and beta blocker combination formulations
EA026727B1 (ru) * 2015-09-10 2017-05-31 Замертон Холдингс Лимитед Соль (1r,2r,3s)-3-(3,4-дихлорфенил)-2-(этоксиметил)-8-метил-8-азабицикло[3.2.1]октана и фталевой кислоты, способ её получения, продукт способа, фармацевтические композиции для лечения и/или профилактики нарушений, связанных с ожирением, их применение и способы лечения и/или профилактики нарушений, связанных с ожирением
US20190060301A1 (en) 2016-01-15 2019-02-28 Saniona A/S Tesofensine and metoprolol for treatment of hypertension
EA028995B1 (ru) * 2016-02-25 2018-01-31 Замертон Холдингс Лимитед Соль тезофензина и оптически активных ацетиламинокислот, их применение для лечения и/или профилактики нарушений, связанных с ожирением
US9949964B2 (en) * 2016-09-07 2018-04-24 Saniona A/S Tesofensine compositions
DE102017210141A1 (de) 2017-06-16 2018-12-20 Henkel Ag & Co. Kgaa Portion zur Bereitstellung tensidhaltiger Flotten
BR112021013463A2 (pt) 2019-01-07 2021-09-14 Saniona A/S Tesofensina para redução do peso corporal em pacientes com prader-willi
MX2022013236A (es) 2020-04-22 2023-01-24 Saniona As Tratamiento de la obesidad hipotalamica.
TWI772928B (zh) * 2020-10-21 2022-08-01 行政院原子能委員會核能研究所 非放射性標準品β-CFT之製備方法
PL4551221T3 (pl) 2022-07-08 2026-04-20 Initiator Pharma A/S Związek do leczenia dysfunkcji seksualnych u samic/kobiet
CN115572289A (zh) * 2022-10-24 2023-01-06 龙曦宁（上海）医药科技有限公司 一种特索芬辛的合成方法
CN120129523A (zh) 2022-10-28 2025-06-10 创始人制药股份有限公司 用于治疗疼痛的化合物
CN120813353A (zh) 2023-01-03 2025-10-17 创始人制药股份有限公司 用于治疗勃起功能障碍的化合物
WO2025051846A1 (en) 2023-09-05 2025-03-13 Initiator Pharma A/S Compound for treatment of female sexual dysfunction

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281130A (en) * 1979-05-24 1981-07-28 Sterling Drug Inc. Lower-alkyl 4,6,7,8,8a-9-hexahydro-6,9-ethanothieno[3,2-f]indolizine-10-carboxylate
US5380848A (en) * 1990-08-09 1995-01-10 Research Triangle Institute Cocaine receptor binding ligands
US5496953A (en) 1990-08-09 1996-03-05 Research Triangle Institute Cocaine receptor binding ligands
US5128118A (en) 1990-08-09 1992-07-07 Research Triangle Institute Cocaine receptor binding ligands
DE69233536D1 (de) * 1991-11-15 2005-08-25 Res Triangle Inst Res Triangle Kokainrezeptor bindende Liganden
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds
AU671163B2 (en) * 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds
AU672644B2 (en) 1992-12-23 1996-10-10 Neurosearch A/S Aryl substituted heterocyclic compounds
EE03877B1 (et) 1994-04-19 2002-10-15 Neurosearch A/S Tropaan-2-aldoksiimi derivaadid neurotransmitteritagasihaarde inhibiitoritena
GB9626611D0 (en) * 1996-12-20 1997-02-05 Unilever Plc Agglomerated silicas

Also Published As

Publication number Publication date
UA49872C2 (uk) 2002-10-15
CZ252098A3 (cs) 1998-11-11
DE69705608T2 (de) 2002-05-16
PL185132B1 (pl) 2003-02-28
EE9800254A (et) 1999-02-15
PT885220E (pt) 2001-11-30
GR3036829T3 (en) 2002-01-31
BG102637A (en) 1999-06-30
WO1997030997A1 (en) 1997-08-28
NZ330886A (en) 1999-02-25
KR19990087127A (ko) 1999-12-15
US6288079B1 (en) 2001-09-11
ES2159839T3 (es) 2001-10-16
PL328503A1 (en) 1999-02-01
SK92998A3 (en) 1998-11-04
US6395748B2 (en) 2002-05-28
BR9707636A (pt) 1999-07-27
TR199801641T2 (xx) 1998-11-23
HUP9901199A3 (en) 2001-02-28
IL125146A (en) 2002-03-10
JP3238414B2 (ja) 2001-12-17
SI0885220T1 (en) 2001-12-31
HUP9901199A2 (hu) 1999-08-30
EE04751B1 (et) 2006-12-15
AU720358B2 (en) 2000-06-01
AU1794097A (en) 1997-09-10
IS1824B (is) 2002-10-01
EP0885220B1 (en) 2001-07-11
ATE203023T1 (de) 2001-07-15
SK281813B6 (sk) 2001-08-06
CN1077574C (zh) 2002-01-09
HU228356B1 (en) 2013-03-28
HK1018957A1 (en) 2000-01-14
IL125146A0 (en) 1999-01-26
NO983877D0 (no) 1998-08-21
US20010018444A1 (en) 2001-08-30
DE69705608D1 (de) 2001-08-16
RU2167876C2 (ru) 2001-05-27
BG63945B1 (bg) 2003-07-31
CN1211982A (zh) 1999-03-24
CZ287007B6 (en) 2000-08-16
CA2244773C (en) 2006-01-03
SG99853A1 (en) 2003-11-27
KR100446571B1 (ko) 2004-11-03
CA2244773A1 (en) 1997-08-28
US20020128284A1 (en) 2002-09-12
EP1130020A1 (en) 2001-09-05
NO983877L (no) 1998-08-21
NO318731B1 (no) 2005-05-02
JP2000504739A (ja) 2000-04-18
IS4825A (is) 1998-08-17
ZA971525B (en) 1997-10-21
EP0885220A1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
NO983877L (no) Tropanderivater, deres fremstilling og anvendelse
IS2164B (is) ß2-adrenvirk viðtaka gerandefni
WO2008034863A3 (en) Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
BRPI0908738A8 (pt) Composto, medicamento, uso de um composto, e, processo para preparar os compostos
UA49796C2 (uk) Ангідрат пароксетин гідрохлориду, спосіб його одержання, сольвати пароксетин гідрохлориду, спосіб їх одержання, спосіб лікування та/або профілактики та фармацевтична композиція
DE502004011551D1 (de) 1,3,4-substituierte pyrazole als 5-ht rezeptor-antagonisten zur behandlung von psychosen und neurologischen störungen
MX2010009643A (es) Derivados de 2-aminoquinolina como antagonistas del receptor 5-hidroxitriptamina (5a).
IL198926A0 (en) Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition
DE60219687D1 (de) Aroylpyrrolheteroeryl und methanole zur behandlung von störungen des zentralnervensystems
ATE452134T1 (de) Zur behandlung von auf eine modulation des dopamin-d3-rezeptors ansprechende erkrankungen geeignete 4-piperazinylpyrimidinverbindungen
PL1635828T3 (pl) Pochodne 4-(2-fenyloksyfenylo)-piperydyny lub 1,2,3,6-tetrahydropirydyny jako inhibitory wychwytu zwrotnego serotoniny
ATE334989T1 (de) Antidepressive azaheterocyclylmethyl-derivate von 2,3-dihydro-1,4-dioxino 2,3-föchinoxalin
WO2007058805A3 (en) Compositions and methods for treating cns disorders
MXPA05010678A (es) Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de recaptacion de serotonina.
WO2003037260A3 (en) Methods and compositions for treating parkinson&#39;s disease
WO2003014114A3 (en) Substituted amine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
IL188115A0 (en) 8-alkoxy-4-methyl-3,4-dihdro-quinazolin-2-
UA81469C2 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
WO2005004867A3 (en) Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor
MX2009006889A (es) Compuestos con una combinacion de antagonismo de cannabinoide-receptor cannabinoide subtipo 1 e inhibicion de acetilcolinesterasa.
CA2521030A1 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors